CDW (US:CDW) ZACKS·2024-10-30 14:35Core Insights - CDW reported $5.52 billion in revenue for Q3 2024, a year-over-year decline of 2% and a surprise of -3.49% compared to the Zacks Consensus Estimate of $5.72 billion [1] - The EPS for the quarter was $2.63, down from $2.72 a year ago, with an EPS surprise of -7.39% against the consensus estimate of $2.84 [1] Revenue Breakdown - Corporate net sales were $2.16 billion, a -2.9% change year-over-year, below the average estimate of $2.26 billion [3] - Small Business net sales reached $379.70 million, a +0.3% year-over-year change, but below the average estimate of $390.58 million [3] - Public Government net sales were $691 million, a -10.9% change year-over-year, compared to the average estimate of $741.24 million [3] - Other net sales amounted to $640 million, a +6.4% year-over-year change, exceeding the average estimate of $619.39 million [3] - Public Healthcare net sales were $649 million, a +4.7% year-over-year change, above the average estimate of $603.26 million [3] - Public net sales totaled $2.34 billion, a -3.6% change year-over-year, below the average estimate of $2.44 billion [3] - Public Education net sales were $995.70 million, a -3% change year-over-year, compared to the average estimate of $1.09 billion [3] Stock Performance - CDW shares returned +1% over the past month, while the Zacks S&P 500 composite returned +1.8% [4] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [4]